Search - tctmd.com

Displaying 181 - 200 of 602

Sort: Relevancy | Date

Presentation TCT 2023

TCT 515: Optimal Antiplatelet Strategy for Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention. A trial-sequential, bivariate, influential, and network meta-analysis

Presenter: Harigopal Sandhyavenu

October 24, 2023

Presentation TCT 2023

New BTK Bioresorbable Stent Technology: Life BTK, The MOTIV-BTK Trial and R3 Clinical Programs

Presenter: Tony Das

October 24, 2023

Presentation TCT 2023

TCT 321: FFR-guided PCI Optimization Directed by High-Definition IVUS Versus Standard of Care: 3-Year Results From the FFR REACT Trial

Presenter: Joost Daemen

October 24, 2023

Presentation TCT 2023

TCT 627: Binary Restenosis Rates Following Percutaneous Transluminal Angioplasty for Below-the-Knee Chronic Limb-Threatening Ischemia: A Meta-Analysis of Randomized Controlled Trial Data

Presenter: Daniel Snyder

October 24, 2023

Presentation TCT 2023

TCT 142: Impact of Chronic Total Occlusions on Outcomes in The FAME 3 Trial

Presenter: Hisao Otsuki

October 24, 2023

Presentation TCT 2023

Importance of Patient Reported Outcomes

Presenter: David Cohen

October 24, 2023

Presentation TCT 2023

TCT 190: The Impact of Age on Fractional Flow Reserve versus Intravascular Ultrasound Guided Percutaneous Coronary Intervention: A FLAVOUR (Fractional Flow Reserve and Intravascular Ultrasound-Guided Intervention Strategy for Clinical Outcomes in…

Presenter: Bong-Ki Lee

October 24, 2023

Presentation TCT 2023

An Echo Deep Dive of the PARTNER 5-Year Study

Presenter: Philippe Pibarot

October 24, 2023

News Conference News TCT 2023

Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials

Michael O'Riordan

October 24, 2023

Presentation TCT 2023

Important Secondary Endpoints From the PARTNER 3 5-YEAR STUDY

Presenter: Raj Makkar

October 24, 2023

Presentation TCT 2023

TCT 253: Medication Adjustments Associated With Implantation of a Cardiac Alerting Device: The ALERTS Trial

Presenter: Andrew Kaplan

October 24, 2023

Presentation TCT 2023

TCT 292: Regional Disparity of the Bypass Strategy and Graft Patent Rate in the Fast-in-man Trial of Coronary Surgical Revascularization Solely Guided on Multislice Computed Tomography

Presenter: SHIGETAKA KAGEYAMA

October 24, 2023

Presentation TCT 2023

Perspectives on Mortality in the PARNTER 5-Year Study

Presenter: Vinod Thourani

October 24, 2023

Presentation TCT 2023

One-Year Outcomes after Amulet or Watchman/FLX Device for Percutaneous Left Atrial Appendage Closure: a Pre-Specified Analysis of the SWISS-APERO Randomized Clinical Trial

Presenter: Roberto Galea

October 24, 2023

News Conference News TCT 2023

WATCH-TAVR: Adding LAAO to TAVI No Worse Than TAVI Alone

Todd Neale

October 24, 2023

Presentation TCT 2023

The Future of Clinical Data for The Reducer

Presenter: Megha Prasad

October 24, 2023

TCT 669: Impact of ACS on Long-Term Clinical Outcomes After PCI With the Biolimus-Coated BioFreedom Stent or Biodegradable Polymer Sirolimus-Eluting Orsiro Stent: From the SORT OUT IX Trial

Presentation TCT 2023

TCT 669: Impact of Acute Coronary Syndromes on Long-Term Clinical Outcomes After Percutaneous Coronary Intervention With the Biolimus-Coated BioFreedom Stent or Biodegradable Polymer Sirolimus-Eluting Orsiro Stent: From the SORT OUT IX Trial

Presenter: Manijeh Noori

October 24, 2023

Presentation TCT 2023

Tendyne SUMMIT Pivotal Trial Roll-In and MAC Arm Outcomes

Presenter: Jason Rogers

October 24, 2023

Presentation TCT 2023

TCT 417: Ten-Year Clinical Outcomes After Randomization to PCI of a Concurrent Chronic Total Coronary Occlusion or Optimal Medical Therapy Alone in Patients With STEMI: Extended Follow-Up of the EXPLORE Trial

Presenter: Anna van Veelen

October 24, 2023

Presentation TCT 2023

Five-year Echocardiographic Outcomes From The PARTNER 3 Low-risk Randomized Trial

Presenter: Rebecca Hahn

October 24, 2023

Advertisement

TCT 515: Optimal Antiplatelet Strategy for Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention. A trial-sequential, bivariate, influential, and network meta-analysis

New BTK Bioresorbable Stent Technology: Life BTK, The MOTIV-BTK Trial and R3 Clinical Programs

TCT 321: FFR-guided PCI Optimization Directed by High-Definition IVUS Versus Standard of Care: 3-Year Results From the FFR REACT Trial

TCT 627: Binary Restenosis Rates Following Percutaneous Transluminal Angioplasty for Below-the-Knee Chronic Limb-Threatening Ischemia: A Meta-Analysis of Randomized Controlled Trial Data

TCT 142: Impact of Chronic Total Occlusions on Outcomes in The FAME 3 Trial

Importance of Patient Reported Outcomes

TCT 190: The Impact of Age on Fractional Flow Reserve versus Intravascular Ultrasound Guided Percutaneous Coronary Intervention: A FLAVOUR (Fractional Flow Reserve and Intravascular Ultrasound-Guided Intervention Strategy for Clinical Outcomes in…

An Echo Deep Dive of the PARTNER 5-Year Study

Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials

Important Secondary Endpoints From the PARTNER 3 5-YEAR STUDY

TCT 253: Medication Adjustments Associated With Implantation of a Cardiac Alerting Device: The ALERTS Trial

TCT 292: Regional Disparity of the Bypass Strategy and Graft Patent Rate in the Fast-in-man Trial of Coronary Surgical Revascularization Solely Guided on Multislice Computed Tomography

Perspectives on Mortality in the PARNTER 5-Year Study

One-Year Outcomes after Amulet or Watchman/FLX Device for Percutaneous Left Atrial Appendage Closure: a Pre-Specified Analysis of the SWISS-APERO Randomized Clinical Trial

WATCH-TAVR: Adding LAAO to TAVI No Worse Than TAVI Alone

The Future of Clinical Data for The Reducer

TCT 669: Impact of Acute Coronary Syndromes on Long-Term Clinical Outcomes After Percutaneous Coronary Intervention With the Biolimus-Coated BioFreedom Stent or Biodegradable Polymer Sirolimus-Eluting Orsiro Stent: From the SORT OUT IX Trial

Tendyne SUMMIT Pivotal Trial Roll-In and MAC Arm Outcomes

TCT 417: Ten-Year Clinical Outcomes After Randomization to PCI of a Concurrent Chronic Total Coronary Occlusion or Optimal Medical Therapy Alone in Patients With STEMI: Extended Follow-Up of the EXPLORE Trial

Five-year Echocardiographic Outcomes From The PARTNER 3 Low-risk Randomized Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content